Forecasting the need for chemotherapy medicines

A software tool called ChemoQuant helps countries with limited resources to forecast their cancer medicine needs, improving care and saving money.

What we did

Cancer is a growing crisis around the world. In sub–Saharan Africa, more than 500,000 people died of cancer in 2015 — a toll that’s expected to double by 2030, according to the World Health Organization.

In many low–income nations, cancer medicines often are in short supply, prohibitively expensive, of poor quality — or a combination of those three. National health ministries need a way to forecast cancer cases so they can order the right chemotherapy treatments in quantities that give them competitive pricing, reliable stock levels and assured quality.

IBM Health Corps experts worked with the American Cancer Society to design and build ChemoQuant — a free, IBM cloud–hosted tool that helps health ministries better forecast their chemotherapy needs. The tool draws upon IBM’s analytics, data science, and cancer epidemiology expertise. ChemoQuant is helping Ethiopia, Uganda and Nigeria forge agreements for access to therapies at significantly lower costs.

Initiative:

Location:

Sub-Saharan Africa

Responsibility Practice:

Health

Addressing Cancer Disparities: IBM Health Corps and the American Cancer Society